Immunocore Holdings Income Statement (2019-2026) | IMCR

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 54.66M59.76M64.85M70.16M70.50M75.40M80.25M84.05M93.88M97.96M103.69M104.48M106.68M
Cost of Revenue (Quarter) 0.22M0.35M0.28M0.20M0.25M1.71M0.45M0.33M0.83M1.04M0.51M2.70M0.43M
Gross Profit (Quarter) 54.44M59.41M64.57M69.96M70.26M73.69M79.80M83.72M93.05M96.92M103.18M101.78M106.24M
Operating items
Research & Development (Quarter) 36.57M38.16M43.25M45.56M57.46M51.07M52.77M60.85M56.47M69.01M70.57M78.82M61.11M
Selling, General & Administrative (Quarter) 32.57M35.01M35.47M41.45M39.29M38.64M35.53M42.32M40.20M42.79M39.78M42.65M37.85M
Operating Expenses (Quarter) 69.14M73.17M78.72M87.01M96.75M89.71M88.30M103.17M96.67M111.80M110.35M121.47M98.96M
Operating Income (Quarter) -14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M-19.69M7.28M
EBIT (Quarter) -14.70M-13.76M-14.14M-17.05M-26.49M-16.02M-8.50M-19.45M-3.62M-14.88M-7.17M-19.69M7.28M
Non-operating items
Interest & Investment Income (Quarter) 3.13M4.28M5.14M5.44M8.25M6.24M5.96M5.17M4.18M4.27M4.12M3.91M3.42M
Other Non Operating Income (Quarter) -6.01M-5.88M11.25M-12.53M-0.19M4.43M3.96M-16.65M5.47M-0.74M5.06M16.05M3.85M
Non Operating Income (Quarter) -0.33M-0.19M-0.19M-0.19M-0.19M4.43M8.96M0.99M5.47M4.69M5.06M4.50M1.78M
Net income details
EBT (Quarter) -19.16M-16.82M0.73M-25.64M-24.08M-10.13M6.09M-24.82M6.08M-9.69M0.30M-15.79M13.27M
Tax Provisions (Quarter) 0.29M0.19M-0.17M-5.91M0.36M1.50M-2.60M-1.05M1.10M0.60M0.48M14.31M0.30M
Profit After Tax (Quarter) -19.45M-17.01M0.91M-19.73M-24.44M-11.62M8.74M-23.77M5.02M-10.30M-0.18M-30.06M12.97M
Income from Continuing Operations (Quarter) -19.45M-17.01M0.91M-19.73M-24.44M-11.63M8.69M-23.77M4.98M-10.29M-0.18M-30.11M12.97M
Consolidated Net Income (Quarter) -19.45M-17.01M0.91M-19.73M-24.44M-11.63M8.69M-23.77M4.98M-10.29M-0.18M-30.11M12.97M
Income towards Parent Company (Quarter) -19.45M-17.01M0.91M-19.73M-24.44M-11.63M8.69M-23.77M4.98M-10.29M-0.18M-30.11M12.97M
Net Income towards Common Stockholders (Quarter) -19.45M-17.01M0.91M-19.73M-24.44M-11.63M8.69M-23.77M4.98M-10.29M-0.18M-30.11M12.97M
Additional items
EPS (Basic) (Quarter) -0.40-0.350.02-0.40-0.49-0.230.17-0.470.10-0.200.00-0.600.26
EPS (Weighted Average and Diluted) (Quarter) -0.40-0.350.02-0.40-0.49-0.230.17-0.470.10-0.200.00-0.600.25
Shares Outstanding (Weighted Average) (Quarter) 28.67M35.02M57.28M53.62M48.18M48.44M49.13M48.89M49.88M49.94M50.02M49.99M50.09M50.29M50.26M50.35M50.75M
Shares Outstanding (Diluted Average) (Quarter) 57.28M53.62M48.18M48.69M48.67M48.89M49.88M49.94M52.81M49.99M51.95M50.19M50.26M50.35M52.93M
EBITDA (Quarter) -12.02M-10.24M-14.04M-0.57M-23.54M-10.67M11.98M-26.36M5.70M-3.82M-3.57M-28.14M5.68M
Interest Expenses (Quarter) 1.25M1.27M1.32M1.31M3.24M4.28M4.29M7.04M3.02M3.04M3.04M3.05M3.05M
Tax Rate (Quarter) -1.53%-1.14%-23.94%23.05%-1.48%-14.81%-42.67%4.23%18.08%-6.19%158.22%-90.63%2.26%